Betalin Therapeutics is a startup based in Israel, 1 tracked investor.
Betalin Therapeutics is a company founded in 2015 headquartered in Israel. Brouky records 1 investor associated with the company.
Betalin Therapeutics is an Israeli biotech company developing an implantable micro‑pancreas that uses transplanted insulin-producing cells and stem-cell technologies to sense blood glucose and release regulated insulin, aiming to reduce or eliminate patients' dependence on injected insulin for diabetes management.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.